Patent details

EP3126521 Title: HNF4G-RSPO2 FUSION GENE

Basic Information

Publication number:
EP3126521
PCT Application Number:
CN2015075882
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP157725896
PCT Publication Number:
WO2015149720
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HNF4G-RSPO2 FUSION GENE
French Title of Invention:
GÈNE DE FUSION DE HNF4G-RSPO2
German Title of Invention:
HNF4G-RSPO2-FUSIONSGEN
SPC Number:

Dates

Filing date:
03/04/2015
Grant date:
20/03/2019
EP Publication Date:
08/02/2017
PCT Publication Date:
08/10/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/03/2019
EP B1 Publication Date:
20/03/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/04/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/03/2019
 
 

Name:
Crown Bioscience, Inc. (Taicang)
Address:
6 Beijing West Road Science and Technology Park Taicang Economie Development Area, Jiangsu 215400, China (CN)

Agent

Name:
KIRKPATRICK
From:
27/03/2019
Address:
AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)
To:

Inventor

1

Name:
LI, Henry
Address:
China (CN)

2

Name:
CAI, Jie
Address:
China (CN)

Priority

Priority Number:
201410135569
Priority Date:
04/04/2014
Priority Country:
China (CN)

Classification

IPC classification:
C12Q 1/6886;

Publication

European Patent Bulletin

Issue number:
201912
Publication date:
20/03/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/04/2027
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/03/2026
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
04/04/2019 Outgoing Correspondence 1
27/03/2019 Power Of Attorney 2